Work

In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx710.006

Authors: I. Datar, M.F. Sanmamed, J. Choi, J. Wang, B.S. Henick, T. Badri, L.D. Mejias, M. Lozano, J.L. Gracia, V. Velcheti, R. Herbst, I. Melero, L. Chen, K.A. Schalper

Institutions: Yale University, Clinica Universidad de Navarra, Universidad de Navarra, Cleveland Clinic, Yale Cancer Center, Smilow Cancer Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2775760675

FWCI: 0.216

Cites:

Cited by: 3

Related to: 10